X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

Xanadu Executes Yale Tech In Developing Intranasal Booster

Content Team by Content Team
21st February 2022
in News
Xanadu Executes Yale Tech In Developing Intranasal Booster

Xanadu Bio, in association with Yale University, has come up with a nanoparticle delivery platform that will help to position itself to give its expertise in the COVID-19 booster vaccines that may prove to be more efficient in stopping the viral infection than the existing or previous products.

Significantly, the first-generation COVID-19 vaccines are very highly effective when it comes to preventing severe disease as well as death, but all said and done, they have proven to be less efficient as far as halting SARS-CoV-2 at a time when coronavirus variants such as Omicron have been very prevalent. Xanadu, which is headed by ex-Roche VP Bruce Turner, is focusing on coming up with a nasal vaccine that will make sure that the virus gets stopped in its tracks.

In a statement, Turner said that Xanadu believes in combining the base technologies developed by the Yale professors, which will further help in introducing the intranasal boosters to thwart SARS-CoV-2. This can be done by killing the virus in the nasosinus itself before it spreads across the deeper parts of the respiratory tract that endanger the patient’s life to a significant extent. By way of killing the virus in the nose itself, transmission amongst the community can be prevented by a great deal.

It is the lipid nanoparticles-LNP that help in delivering mRNA through the intramuscular route. However, research suggests that it may be unsuitable for nasal delivery. In one of the studies, giving LNP via the nasal route to mice led to inflammation and death. The researchers from Yale, however, have designed the PACE materials, which are licenced by Xanadu, that are relatively more silent immunologically and hence can be administered through the respiratory tract.

It was late last month when the researchers got to witness certain early evidence that suggested that the objective may have been achieved. Yale scientists published their findings on the effect mRNA had when it was encapsulated along with PACE polymers and given to mice.

Xanadu has now taken ownership of advancing its candidates based on this very technology. The biotech company has exclusively taken the rights of PACE and also explored as well as executed options with Yale as far as the nasal delivery of spike mRNA/PACE and other recombinant proteins are concerned.

Previous Post

Quotient Sciences completes integration of drug substance into Translational Pharmaceutics Platform

Next Post

To Grow Biologics Recipharm Buys Arranta And Vibalogics

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
Recipharm supports FDA approval of Perrigos AB-rated generic product

To Grow Biologics Recipharm Buys Arranta And Vibalogics

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In